Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

G. Schlimok · SciRah

Researcher profile · Semantic Scholar

G. Schlimok

Share profile

G. Schlimok — researcher profile on SciRah

h-index: 41
Works: 128
Citations: 11K

Most-cited papers

A pooled analysis of bone marrow micrometastasis in breast cancer.
S. Braun, F. Vogl, B. Naume, W. Janni +18 more
2005New England Journal of Medicine1,371 citations Open access
Semantic Scholar
Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
S. Braun, K. Pantel, P. Müller, W. Janni +8 more
2000New England Journal of Medicine968 citations Open access
Semantic Scholar
Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma
G. Riethmüller, R. Gruber, E. Schneider-Gädicke, G. Schlimok +11 more
1994667 citations
Semantic Scholar
From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression
O. Schmidt-Kittler, Thomas Ragg, A. Daskalakis, M. Granzow +12 more
2003Proceedings of the National Academy of Sciences of the United States of America653 citations Open access
Semantic Scholar
Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial.
G. Riethmüller, E. Holz, G. Schlimok, W. Schmiegel +9 more
1998Journal of Clinical Oncology551 citations
Semantic Scholar
Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells.
K. Pantel, G. Schlimok, S. Braun, D. Kutter +5 more
1993Journal of the National Cancer Institute524 citations
Semantic Scholar
Re: Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
S. Braun, M. Müller, F. Hepp, G. Schlimok +2 more
1996Journal of the National Cancer Institute436 citations Open access
Semantic Scholar
Methodological Analysis of Immunocytochemical Screening for Disseminated Epithelial Tumor Cells in Bone Marrow
K. Pantel, G. Schlimok, M. Angstwurm, D. Weckermann +5 more
1994Journal of Hematotherapy328 citations
Semantic Scholar
Combined transcriptome and genome analysis of single micrometastatic cells
C. Klein, Stefan Seidl, Karina Petat‐Dutter, S. Offner +8 more
2002Nature Biotechnology298 citations
Semantic Scholar
Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow.
A. Zippelius, P. Kufer, G. Honold, M. Köllermann +4 more
1997Journal of Clinical Oncology293 citations
Semantic Scholar
Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.
Katharina Wagner, F. Damm, G. Göhring, Kerstin Görlich +16 more
2010Journal of Clinical Oncology254 citations
Semantic Scholar
ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients.
S. Braun, G. Schlimok, Isabella Heumos, G. Schaller +3 more
2001Cancer Research199 citations
Semantic Scholar
Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia.
F. Thol, F. Damm, Katharina Wagner, G. Göhring +13 more
2010Blood194 citations Open access
Semantic Scholar
Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors
O. Solakoglu, C. Maierhofer, G. Lahr, E. Breit +9 more
2002Proceedings of the National Academy of Sciences of the United States of America175 citations Open access
Semantic Scholar
Perioperative activation of disseminated tumor cells in bone marrow of patients with prostate cancer.
D. Weckermann, B. Polzer, Thomas Ragg, A. Blana +5 more
2009Journal of Clinical Oncology157 citations
Semantic Scholar
Establishment of micrometastatic carcinoma cell lines: a novel source of tumor cell vaccines.
K. Pantel, A. Dickmanns, A. Zippelius, C. Klein +7 more
1995Journal of the National Cancer Institute133 citations
Semantic Scholar
Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia.
F. Damm, M. Heuser, M. Morgan, Hai-Yang Yun +16 more
2010Journal of Clinical Oncology125 citations
Semantic Scholar
Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study.
W. Brugger, J. Hirsch, F. Grünebach, Roland Repp +11 more
2004Annals of Oncology115 citations Open access
Semantic Scholar
Myeloid blast crisis evolving during imatinib treatment of an FIP1L1-PDGFR alpha-positive chronic myeloproliferative disease with prominent eosinophilia
N. von Bubnoff, M. Sandherr, G. Schlimok, R. Andreesen +2 more
2005Leukemia107 citations
Semantic Scholar
Disseminated cytokeratin positive tumor cells in the bone marrow of patients with prostate cancer: detection and prognostic value.
D. Weckermann, P. Müller, F. Wawroschek, R. Harzmann +2 more
2001Journal of Urology104 citations
Semantic Scholar
Detection of genetic alterations in micrometastatic cells in bone marrow of cancer patients by fluorescence in situ hybridization.
P. Müller, D. Weckermann, G. Riethmüller, G. Schlimok
1996Cancer Genetics and Cytogenetics83 citations
Semantic Scholar
Reduction of metastatic carcinoma cells in bone marrow by intravenously administered monoclonal antibody: towards a novel surrogate test to monitor adjuvant therapies of solid tumours.
G. Schlimok, K. Pantel, H. Loibner, I. Fackler-Schwalbe +1 more
1995European Journal of Cancer78 citations
Semantic Scholar
Detection and Characterization of Residual Disease in Breast Cancer
K. Pantel, Erich Felber, G. Schlimok
1994Journal of Hematotherapy73 citations
Semantic Scholar
Dose-escalated CHOP plus etoposide (MegaCHOEP) followed by repeated stem cell transplantation for primary treatment of aggressive high-risk non-Hodgkin lymphoma.
B. Glass, M. Kloess, M. Bentz, G. Schlimok +6 more
2006Blood64 citations Open access
Semantic Scholar
Risk-adapted induction and consolidation therapy in adults with de novo AML aged ≤ 60 years: results of a prospective multicenter trial
G. Heil, J. Krauter, A. Raghavachar, Lothar Bergmann +8 more
2004Annals of Hematology56 citations
Semantic Scholar
p53 gene mutations are not required for early dissemination of cancer cells.
S. Offner, W. Schmaus, K. Witter, G. Baretton +4 more
1999Proceedings of the National Academy of Sciences of the United States of America55 citations Open access
Semantic Scholar
Reliable Single Cell Array CGH for Clinical Samples
Z. Czyż, Martin Hoffmann, G. Schlimok, B. Polzer +1 more
2014PLoS ONE54 citations Open access
Semantic Scholar
Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer.
Marcus Schmidt, D. Ruttinger, M. Sebastian, C. Hanusch +11 more
2012Annals of Oncology48 citations Open access
Semantic Scholar
A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma
H. Einsele, Michael Bamberg, W. Budach, H. Schmidberger +19 more
2003Bone Marrow Transplantation48 citations Open access
Semantic Scholar
Micrometastases of bone marrow in localized prostate cancer: correlation with established risk factors.
D. Weckermann, P. Müller, F. Wawroschek, G. Krawczak +2 more
1999Journal of Clinical Oncology48 citations
Semantic Scholar
Minimal residual epithelial cancer: diagnostic approaches and prognostic relevance.
K. Pantel, S. Braun, B. Passlick, G. Schlimok
1996Progress in Histochemistry and Cytochemistry44 citations
Semantic Scholar
Randomized comparison of pegfilgrastim day 4 versus day 2 for the prevention of chemotherapy-induced leukocytopenia.
C. Zwick, F. Hartmann, S. Zeynalova, Viola Pöschel +9 more
2011Annals of Oncology43 citations Open access
Semantic Scholar
COMMENT ON : MICROMETASTATIC BREAST CANCER CELLS IN BONE MARROW AT PRIMARYSURGERY : PROGNOSTIC VALUE IN COMPARISON WITH NODAL STATUS. AUTHORS' REPLY
S. Braun, M. Muller, F. Hepp, G. Schlimok +5 more
199842 citations
Semantic Scholar
Systematic comparison of sporadic and syndromic pancreatic islet cell tumors.
Zoran Erlic, U. Ploeckinger, A. Cascón, M. M. Hoffmann +33 more
2010Endocrine-Related Cancer37 citations Open access
Semantic Scholar
Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas.
H. Gerhartz, M. Engelhard, P. Meusers, G. Brittinger +6 more
1993Blood35 citations
Semantic Scholar
Influence of molecular subgroups on outcome of acute myeloid leukemia with normal karyotype in 141 patients undergoing salvage allogeneic stem cell transplantation in primary induction failure or beyond first relapse
T. Pfeiffer, M. Schleuning, J. Mayer, K. Haude +16 more
2013Haematologica32 citations Open access
Semantic Scholar
Bone marrow “micrometastases” of epithelial tumors: detection and clinical relevance
P. Müller, G. Schlimok
2000Journal of Cancer Research and Clinical Oncology31 citations Open access
Semantic Scholar
Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group.
G. Riethmüller, E. Schneider-Gädicke, G. Schlimok, W. Schmiegel +6 more
1994The Lancet29 citations
Semantic Scholar
Occult epithelial tumor cells detected in bone marrow by an enzyme immunoassay specific for cytokeratin 19
Wilma Hochtlen-Vollmar, R. Gruber, H. Bodenmuller, Erich Felber +5 more
1997International Journal of Cancer26 citations Open access
Semantic Scholar
Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas: results of a randomized double-blind placebo-controlled study with intensified COP-BLAM +/- rhGM-CSF.
M. Engelhard, H. Gerhartz, G. Brittinger, A. Engert +25 more
1994Annals of Oncology26 citations Open access
Semantic Scholar
Combination of high-dose chemotherapy and monoclonal antibody in breast-cancer patients: a pilot trial to monitor treatment effects on disseminated tumor cells.
P. Hempel, P. Müller, D. Oruzio, W. Behr +5 more
2000Cytotherapy24 citations
Semantic Scholar
Evaluation of bone marrow in breast cancer patients: prediction of clinical outcome and response to therapy.
S. Braun, F. Vogl, W. Janni, C. Marth +2 more
2003Breast22 citations Open access
Semantic Scholar
Role of Consolidation Therapy in the Treatment of Patients up to 60 Years with High Risk AML.
J. Krauter, G. Heil, D. Hoelzer, O. Ottmann +12 more
200521 citations
Semantic Scholar
[Do ultrasound-guided core needle biopsies of lymph nodes allow for subclassification of malignant lymphomas?].
J. Demharter, S. Neukirchen, T. Wagner, G. Schlimok +2 more
2007RöFo. Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren (Print)18 citations
Semantic Scholar
Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction
Michele Pohlen, N. Thoennissen, J. Braess, Johannes Thudium +18 more
2016PLoS ONE17 citations Open access
Semantic Scholar
Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy.
C. Straka, M. Sandherr, H. Salwender, H. Wandt +19 more
2011Blood17 citations
Semantic Scholar
[T-lymphocyte subpopulation and HLA-DR antigens in hearing loss of vestibular neuropathy, Ménière's diseases and Bell's palsy].
P. Bumm, E. Müller, U. Grimm-Müller, G. Schlimok
2008Laryngo-Rhino-Otologie16 citations
Semantic Scholar
Association between structural and numerical chromosomal aberrations in acute myeloblastic leukemia: a study by RT-PCR and FISH in 447 patients with de-novo AML
J. Krauter, A. Ganser, Lothar Bergmann, A. Raghavachar +7 more
1999Annals of Hematology16 citations
Semantic Scholar
[Hereditary vascular malformations: classification, symptoms, diagnostics and prognosis].
W. Wohlgemuth, K. Wölfle, T. Schuster, G. Schlimok +1 more
2011Zentralblatt für Chirurgie13 citations
Semantic Scholar
Phase III trial of irinotecan plus oxaliplatin (IROX) versus irinotecan plus 5-FU/folinic acid (FOLFIRI) as first-line treatment of metastatic colorectal cancer (CRC): The FIRE-Trial
A. Schalhorn, F. Ludwig, D. Quietzsch, P. Maubach +7 more
200513 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

G. Riethmüller×17
Invite
G. Riethmüller — researcher profile on SciRah
K. Pantel×13
Invite
K. Pantel — researcher profile on SciRah
P. Müller×8
Invite
P. Müller — researcher profile on SciRah
S. Braun×7
Invite
S. Braun — researcher profile on SciRah

×6

Invite

D. Weckermann — researcher profile on SciRah

Invite

M. Lübbert — researcher profile on SciRah

Invite

H. Kirchner — researcher profile on SciRah

Invite

C. Klein — researcher profile on SciRah

Invite

G. Heil — researcher profile on SciRah

Invite

A. Ganser — researcher profile on SciRah

Invite

J. Krauter — researcher profile on SciRah

Invite

W. Heit — researcher profile on SciRah